Avanos Medical (AVNS) EBITDA Margin (2013 - 2026)
Avanos Medical (AVNS) posted EBITDA Margin of 4.88% for Q1 2026, up 253.46% sequentially from 1.38% in Q4 2025, and down 126.0% YoY from 18.79% in Q1 2025.
Avanos Medical (AVNS) EBITDA Margin (2013 - 2026) Analysis & Trends
Avanos Medical has reported EBITDA Margin for 14 years, with the latest figure at 4.88% in Q1 2026.
- Quarterly EBITDA Margin fell 126.0% year-over-year to 4.88% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 8.8% (up 4777.0% YoY) and the FY2025 annual result came in at 8.78%, up 4882.0% from the prior year.
- EBITDA Margin grew to 4.88% in Q1 2026 per AVNS's latest filing, from 1.38% in the prior quarter.
- Over five years, EBITDA Margin peaked at 9.14% in Q4 2022 and troughed at 233.02% in Q4 2024.
- A 5-year average of 13.0% and a median of 3.67% in 2024 frame the typical range for EBITDA Margin.
- The sharpest annual moves came in 2024 and 2025: EBITDA Margin tumbled 23948 bps in 2024, then soared 23440 bps in 2025.
- Over 5 years, EBITDA Margin stood at 9.14% in 2022, then fell by 29 bps to 6.46% in 2023, then tumbled by 3706 bps to 233.02% in 2024, then surged by 101 bps to 1.38% in 2025, then jumped by 253 bps to 4.88% in 2026.
- According to Business Quant data, EBITDA Margin over the past three periods registered 4.88%, 1.38%, and 0.06% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 13.44% |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 25.18% |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 21.65% |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 29.48% |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 24.33% |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 13.96% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 10.30% |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 19.15% |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn | 4.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.88% |
| Dec 31, 2025 | 1.38% |
| Sep 30, 2025 | 0.06% |
| Jun 30, 2025 | -42.57% |
| Mar 31, 2025 | 6.15% |
| Dec 31, 2024 | -233.02% |
| Sep 30, 2024 | 7.04% |
| Jun 30, 2024 | 3.67% |
| Mar 31, 2024 | 2.41% |
| Dec 31, 2023 | 6.46% |
| Sep 30, 2023 | 0.70% |
| Jun 30, 2023 | -1.24% |
| Mar 31, 2023 | -3.83% |
| Dec 31, 2022 | 9.14% |
| Sep 30, 2022 | 7.43% |
| Jun 30, 2022 | 5.91% |
| Mar 31, 2022 | 4.36% |
| Dec 31, 2021 | -62.57% |
| Sep 30, 2021 | 1.85% |
| Jun 30, 2021 | -3.92% |